Tuesday, June 26, 2012

Daily News Digest: Reuters Health News Headlines - Yahoo! News

Daily News Alert
Yahoo! Alerts Yahoo! News | My Alerts | Edit Alert
Tuesday, June 26, 2012 8:31 PM PDT
Today's Reuters Health News Headlines - Yahoo! News:
Chavez sees no more cancer treatment on horizon
Tue,26 Jun 2012 07:24 PM PDT
Reuters -

Hugo Chavez talks to the media during the welcoming ceremony of Alexander Lukashenko at Miraflores Palace in CaracasCARACAS (Reuters) - Venezuelan President Hugo Chavez said on Tuesday he sees no need for further treatment for the cancer that struck him last year just weeks after he had said medical tests showed him in good health. Although polls show Chavez comfortably ahead, any relapse in his undisclosed type of cancer could upend his October 7 re-election bid against opposition challenger Henrique Capriles. "I've already done what I need to do," Chavez said when asked if he planned to undergo any more cancer treatment. "At this moment, on the horizon that I can see ... ...


Full Story
Top

China sacks official, punishes others in forced abortion case
Tue,26 Jun 2012 07:05 PM PDT
Reuters - BEIJING (Reuters) - Chinese officials have fired a local family planning official and punished several others after a woman was forced to abort her seven-month pregnancy, sparking a firestorm domestically and around the world, China's government-run media reported. Feng Jianmei's abortion was portrayed in the Chinese and international press as an example of the extreme measures some officials would take to control China's population, even if it meant breaking Chinese law. China has used strict family planning policies since the 1970s to control its population, now at 1.34 billion. ... Full Story
Top

Consumer group urges FDA to reject Arena diet drug
Tue,26 Jun 2012 02:48 PM PDT
Reuters - (Reuters) - Watchdog group Public Citizen urged U.S. regulators on Tuesday not to approve Arena Pharmaceuticals Inc's experimental diet pill lorcaserin, citing concerns it could increase patients' risk of heart valve damage. The U.S. Food and Drug Administration is expected to rule on whether to approve the drug by Wednesday. Public Citizen, a nonprofit consumer advocacy group, said physicians at last month's FDA advisory panel meeting on lorcaserin raised serious concerns about evidence of increased valve disease risks in patients who used the drug in clinical trials. ... Full Story
Top

Mystery ahoof as U.S. cattle dying after eating grass
Tue,26 Jun 2012 02:32 PM PDT
Reuters - DALLAS, Texas (Reuters) - A mystery is ahoof in Texas farm country where cattle have dropped dead while grazing, puzzling scientists who say it appears an unusual combination of circumstances have turned pastures toxic. Texas animal scientists said a type of grass known as "Tifton 85" bermuda grass is to blame for the poisoning of 15 head of cattle on an 80-acre ranch east of Austin. The animals went into convulsions and were dead within hours of being released into the pasture to graze. Only three cattle in that small herd survived. ... Full Story
Top

Women's lung cancer deaths up in South and Midwest
Tue,26 Jun 2012 02:15 PM PDT
Reuters - NEW YORK (Reuters Health) - Despite falling lung cancer rates across the U.S. in the past decade, researchers report that deaths from the disease are steady or rising among middle-aged women in southern and Midwestern states. The findings, published Monday in the Journal of Clinical Oncology, point to a need for more aggressive policies and strategies for reducing smoking by a new generation of men and women, in all U.S. states. ... Full Story
Top

U.S. group flags chemical levels in Coke sold abroad
Tue,26 Jun 2012 02:11 PM PDT
Reuters - (Reuters) - Coca-Cola Co's namesake soda sold in several countries, including Brazil and Kenya, still contains a high level of a chemical linked to cancer in animals months after it made changes to the drinks sold in California, a U.S. watchdog group said on Tuesday. The Center for Science in the Public Interest said that samples of Coca-Cola tested in nine countries showed "alarming amounts" of the chemical 4-methylimidazole, or 4-MI, used as an ingredient in caramel coloring. High levels of that chemical have been linked to cancer in animals. ... Full Story
Top

Walgreen, others offer free HIV tests in CDC pilot
Tue,26 Jun 2012 01:49 PM PDT
Reuters -

A sign for a Walgreens store is seen in Belle Glade, FloridaWASHINGTON (Reuters) - U.S. drugstore chain Walgreen Co and several other pharmacies are offering free, rapid HIV tests in a small number of stores under a two-year pilot program to make diagnosing the AIDS virus more convenient and accessible to Americans. The pilot program announced on Tuesday by the U.S. Centers for Disease Control and Prevention (CDC) will use information gleaned from the testing to develop a nationwide model for pharmacists and nurse practitioners to detect the virus. "Our goal is to make HIV testing as routine as a blood pressure check," said Jonathan Mermin, M.D. ...


Full Story
Top

White House says ready for Supreme Court health decision
Tue,26 Jun 2012 01:41 PM PDT
Reuters -

Doctor Murthy stands outside the Supreme Court during legal arguments over the Affordable Care Act in WashingtonABOARD AIR FORCE ONE (Reuters) - The White House said on Tuesday it was ready for a Supreme Court verdict on President Barack Obama's flagship health reform law and remained convinced the legislation would be upheld. "We are, as I have said in the past, confident that the Affordable Care Act is constitutional, in keeping with decades of precedent under the commerce clause," White House spokesman Jay Carney told reporters aboard Air Force One. "We continue to implement the law accordingly and we are ready for the Supreme Court's decision, whatever it may be. ...


Full Story
Top

Romney presses attacks on "Obamacare" before ruling
Tue,26 Jun 2012 01:36 PM PDT
Reuters -

Republican presidential candidate Romney addresses the National Association of Latino Elected and Appointed Officials Annual Conference in Lake Buena VistaSALEM, Virginia (Reuters) - Republican Mitt Romney stepped up his criticism on Tuesday of President Barack Obama's signature domestic policy achievement, saying if the U.S. Supreme Court does not overturn the 2010 healthcare overhaul when it decides its fate this week he would dump it if elected in November. Eager to change the subject back to Obama's economic stewardship after nearly two difficult weeks focusing on immigration, Romney accused Obama of taking his eye off the ball when he pushed the healthcare measure through Congress in 2010. ...


Full Story
Top

Electronic records tied to fewer malpractice claims
Tue,26 Jun 2012 01:23 PM PDT
Reuters - NEW YORK (Reuters Health) - Doctors who start using electronic health records are less likely to get sued than their colleagues who stick with traditional paper records, according to new findings from Massachusetts. The technology is being introduced with the goal of decreasing errors and streamlining patient care. But some researchers have worried that in transitioning to electronic records doctors could make more mistakes using new and unfamiliar systems - such as writing notes and prescribing drugs in the wrong patient's record. ... Full Story
Top

"Stepped-care" is cheaper, effective for weight loss
Tue,26 Jun 2012 01:12 PM PDT
Reuters - NEW YORK (Reuters Health) - Helping heavy people lose weight is typically an expensive endeavor, but new research suggests starting them on a basic weight-loss program - and only adding more intensive help if they need it - could be cheaper and still effective. So-called stepped-care is used all the time in medicine, said Robert Klesges, a preventive medicine researcher from the University of Tennessee Health Science Center in Memphis, who has studied the approach. ... Full Story
Top

FDA warns Covidien on violations related to patient deaths
Tue,26 Jun 2012 11:30 AM PDT
Reuters - (Reuters) - U.S. health regulators censured Covidien Plc for failing to promptly address complaints related to deaths and serious injuries linked to its devices used in thoracic surgery. Covidien in January said it would recall all production lots of its Duet TRS units, after it received reports of 13 serious injuries and three deaths. The U.S. Food and Drug Administration said the company had received numerous complaints related to the use of the product since May 2009. ... Full Story
Top

The immigration ruling: a hint on healthcare?
Tue,26 Jun 2012 11:15 AM PDT
Reuters -

People hold signs as they gather during a protest against Senate Bill 1070 in PhoenixWASHINGTON (Reuters) - The Supreme Court's decision in the Arizona immigration case on Monday showed a conciliatory streak within a divided court that could emerge again when the justices issue their climactic healthcare decision on Thursday. What the Arizona compromise will augur for the most closely watched case of the term is anyone's guess. Yet the justices' evident search for common ground in the immigration ruling and a few other cases this term could portend a healthcare decision that does not predictably cleave along political lines. ...


Full Story
Top

Vaccinations cleared in babies' celiac "epidemic"
Tue,26 Jun 2012 09:47 AM PDT
Reuters - NEW YORK (Reuters Health) - A surge in celiac disease cases among babies and toddlers in Sweden was not related to childhood vaccinations, a new study finds. Celiac disease is a digestive disorder caused by an abnormal immune response to gluten, a protein in wheat, rye and barley. The disease damages structures in the lining of the small intestine, which then interferes with the body's absorption of nutrients. Particular gene variants may make people susceptible to celiac disease. ... Full Story
Top

Novartis, four others weigh Amylin final bids: sources
Tue,26 Jun 2012 09:42 AM PDT
Reuters -

A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in BaselNEW YORK (Reuters) - Five pharmaceutical giants including Novartis AG and Sanofi SA remain in the running for Amylin Pharmaceuticals Inc, as the auction of the diabetes drugmaker with a market value of $4.5 billion enters the last leg, according to people familiar with the matter. Bristol-Myers Squibb Co, AstraZeneca Plc and Merck & Co Inc also remain involved, the people said. Final bids are expected starting the end of this week, they said. All of the potential acquirers declined to comment. Amylin was not immediately available for comment. Shares of Amylin rose 2 percent to $28. ...


Full Story
Top



You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment